Overview
APELOA
?
Fangmeng Zhu
See more contacts
Scientific Research and Development Services
,
Drugs and Druggists' Sundries Merchant Wholesalers
,
Professional, Scientific, and Technical Services
,
Medical research
,
Medical research, commercial
See All Industries Drugs, proprietaries, and sundries
See Fewer Industries
See All Industries Drugs, proprietaries, and sundries
See Fewer Industries
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Computer Systems Design and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Other Professional, Scientific, and Technical Services
,
Specialized Design Services
?
?
?
Actual
?
Actual
$1.66 billion
Actual
4.77%
-2.29%
$12,729
DEC
?
?
Shenzhen:000739
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$1.66 billion
USD
Actual
1 USD = 7.2455 CNY
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $167 | $142 | $183 |
| Net Investing Cash | -$55 | -$93 | -$82 |
| Net Financing Cash | -$80 | -$42 | -$27 |
| Net Change in Cash | $32 | $7 | $74 |
| Cash at Beginning of Period | $340 | $329 | $248 |
| Cash at End of Period | $377 | $340 | $329 |
| Capital Expenditure | -$64 | -$87 | -$70 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $505 | $494 | $490 |
| Accounts Receivable | $243 | $234 | $230 |
| Inventories | $257 | $288 | $249 |
| Other Current Assets | $124 | $139 | $105 |
| Asset Summary | |||
| Total Current Assets | $1,130 | $1,155 | $1,074 |
| Tangible Fixed Assets | $521 | $492 | $470 |
| Intangible Assets | $43 | $44 | $52 |
| Total Assets | $12,729 | $12,768 | $12,021 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $501 | $570 | $595 |
| Short-Term Debt | $112 | $111 | $78 |
| Other Current Liabilities | $179 | $190 | $159 |
| Liability Summary | |||
| Total Current Liabilities | $793 | $871 | $832 |
| Long-Term Debt | $10 | $3 | $34 |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $825 | $902 | $897 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $161 | $163 | $163 |
| Retained Earnings | $708 | $624 | $532 |
| Equity Summary | |||
| Total Equity | $931 | $859 | $761 |
| Shares Outstanding | 1,169,323,576 | 1,178,523,492 | 1,178,523,492 |